Patent details

EP3626253 Title: STABLE FORMULATIONS OF LINACLOTIDE

Basic Information

Publication number:
EP3626253
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP191913441
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
STABLE FORMULATIONS OF LINACLOTIDE
French Title of Invention:
FORMULATIONS STABLES DE LINACLOTIDE
German Title of Invention:
STABILE LINACLOTIDFORMULIERUNGEN
SPC Number:

Dates

Filing date:
11/08/2011
Grant date:
16/03/2022
EP Publication Date:
25/03/2020
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
16/03/2022
EP B1 Publication Date:
16/03/2022
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
11/08/2022
Expiration date:
11/08/2031
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
25/02/2022
 
 

Name:
Allergan Pharmaceuticals International Limited
Address:
Clonshaugh Business & Technology Park, Coolock, D17 E400, Dublin, Ireland (IE)

Name:
Ironwood Pharmaceuticals, Inc.
Address:
301 Binney Street, Cambridge, MA 02142, United States (US)

History of Owners

From:
09/03/2022
To:
25/02/2022

Name:
Forest Laboratories Holdings Limited
Address:
Victoria Place, 5th Floor 31 Victoria Street, Hamilton, Bermuda (BM)

Name:
Ironwood Pharmaceuticals, Inc.
Address:
301 Binney Street, Cambridge, MA 02142, United States (US)

Inventor

1

Name:
CALI, Brian
Address:
United States (US)

2

Name:
MO, Yun
Address:
United States (US)

3

Name:
FRETZEN, Angelika
Address:
United States (US)

4

Name:
DEDHIYA, Mahendra
Address:
United States (US)

Priority

Priority Number:
37280410 P
Priority Date:
11/08/2010
Priority Country:
United States (US)

Classification

IPC classification:
A61K 38/10; A61K 9/20; A61K 47/18; A61P 1/00;

Publication

European Patent Bulletin

1

Issue number:
202211
Publication date:
16/03/2022
Description:
Grant (B1)

2

Issue number:
202213
Publication date:
30/03/2022
Description:
Transfer of Rights

3

Issue number:
202216
Publication date:
20/04/2022
Description:
Document reprinted after correction (B8, B9)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages